Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Genomic Biomarkers Market, by Region, 2018-2027 (USD Billion)
1.2.2. Genomic Biomarkers Market, by Application, 2018-2027 (USD Billion)
1.2.3. Genomic Biomarkers Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Genomic Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Genomic Biomarkers Market Dynamics
3.1. Genomic Biomarkers Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Genomic Biomarkers Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Genomic Biomarkers Market, by Application
5.1. Market Snapshot
5.2. Global Genomic Biomarkers Market by Application, Performance - Potential Analysis
5.3. Global Genomic Biomarkers Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
5.4. Genomic Biomarkers Market, Sub Segment Analysis
5.4.1. Oncology
5.4.2. Cardiovascular diseases
5.4.3. Neurological diseases
5.4.4. Others
Chapter 6. Global Genomic Biomarkers Market, by End-User
6.1. Market Snapshot
6.2. Global Genomic Biomarkers Market by End-User - Potential Analysis
6.3. Global Genomic Biomarkers Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
6.4. Genomic Biomarkers Market, Sub Segment Analysis
6.4.1. Diagnostic and research laboratories
6.4.2. Hospitals
6.4.3. Others
Chapter 7. Global Genomic Biomarkers Market, Regional Analysis
7.1. Genomic Biomarkers Market, Regional Market Snapshot
7.2. North America Genomic Biomarkers Market
7.2.1. U.S. Genomic Biomarkers Market
7.2.1.1. Application breakdown estimates & forecasts, 2017-2027
7.2.1.2. End-User breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Genomic Biomarkers Market
7.3. Europe Genomic Biomarkers Market Snapshot
7.3.1. U.K. Genomic Biomarkers Market
7.3.2. Germany Genomic Biomarkers Market
7.3.3. France Genomic Biomarkers Market
7.3.4. Spain Genomic Biomarkers Market
7.3.5. Italy Genomic Biomarkers Market
7.3.6. Rest of Europe Genomic Biomarkers Market
7.4. Asia-Pacific Genomic Biomarkers Market Snapshot
7.4.1. China Genomic Biomarkers Market
7.4.2. India Genomic Biomarkers Market
7.4.3. Japan Genomic Biomarkers Market
7.4.4. Australia Genomic Biomarkers Market
7.4.5. South Korea Genomic Biomarkers Market
7.4.6. Rest of Asia Pacific Genomic Biomarkers Market
7.5. Latin America Genomic Biomarkers Market Snapshot
7.5.1. Brazil Genomic Biomarkers Market
7.5.2. Mexico Genomic Biomarkers Market
7.6. Rest of The World Genomic Biomarkers Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Thermo Fisher Scientific Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. F. Hoffmann-La Roche Ltd.
8.2.3. Aepodia SA
8.2.4. Myriad Genetics Inc.
8.2.5. Eurofins Scientific
8.2.6. Qiagen
8.2.7. Bio-Rad Laboratories Inc.
8.2.8. Almac Group
8.2.9. Aros Applied Biotechnology A/S
8.2.10. EpiGenomic AG
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption